Daridorexant (ACT-541468), a new dual orexin receptor...

Sleep Medicine 2019 / 12 Vol. 64

Daridorexant (ACT-541468), a new dual orexin receptor antagonist, for the treatment of insomnia disorder in the elderly: results from a randomized, double-blind, placebo-controlled, 5-period, 5-treatment crossover dose-response phase 2 study

Zammit, G., Dauvilliers, Y., Pain, S., Sebök Kinter, D., Kunz, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
64
Journal:
Sleep Medicine
DOI:
10.1016/j.sleep.2019.11.1228
Date:
December, 2019
File:
PDF, 72 KB
2019
Conversion to is in progress
Conversion to is failed